Obesity
Showing NaN - NaN of 95
Obesity Trial in Nashville (Pentoxifylline, Placebo)
Completed
- Obesity
- Pentoxifylline
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 24, 2017
Physical Activity, Weight and Fitness Outcomes in After-Care
Completed
- Obesity
- Exercise
-
Nashville, Tennessee
- +1 more
Nov 2, 2017
Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Goodyear, Arizona
- +36 more
Sep 29, 2017
Obesity Trial in Nashville (Bradykinin)
Terminated
- Obesity
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 13, 2017
Obesity Trial in Nashville (radiation, procedure, behavioral, other)
Completed
- Obesity
- PET scan
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 29, 2017
Metabolic Syndrome, Obesity Trial in Nashville (Sildenafil, Placebo)
Completed
- Metabolic Syndrome
- Obesity
- Sildenafil
- Placebo
-
Nashville, TennesseeVanderbilt University
Feb 22, 2017
Obesity, Overweight, Craniopharyngioma Trial in Nashville (Exenatide)
Completed
- Obesity
- +2 more
-
Nashville, TennesseeVanderbilt University
Jan 17, 2017
Obesity Trial in Nashville (omentectomy)
Completed
- Obesity
- omentectomy
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 30, 2017
Prader-Willi Syndrome, Obesity Trial in United States (ZGN-440 for Injectable Suspension, ZGN-440 Placebo for Injectable
Terminated
- Prader-Willi Syndrome
- Obesity
- ZGN-440 for Injectable Suspension
- ZGN-440 Placebo for Injectable Suspension
-
Sacramento, California
- +14 more
Jan 24, 2017
Factors Involved in Obesity-related Inflammation and Insulin
Terminated
- Obesity
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 19, 2017
Obesity, Insulin Resistance, Normal Weight,Healthy Controls Trial in Nashville (Ghrelin infusion to assess effects on insulin
Completed
- Obesity
- +2 more
- Ghrelin infusion to assess effects on insulin sensitivity
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 18, 2017
Obesity, Hypertension Trial in Nashville (L-NMMA, Trimethaphan)
Completed
- Obesity
- Hypertension
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 16, 2017
CD36 Deficiency in African Americans
Completed
- Obesity
-
Nashville, TennesseeVanderbilt University
Dec 29, 2016
Obesity Trial in Nashville (Cytokines assessed from fat tissue)
Completed
- Obesity
- Cytokines assessed from fat tissue
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 17, 2016
Obesity Trial in Nashville (Blocked, Intact)
Completed
- Obesity
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 6, 2016
Obesity, Over-weight, Hypothalamic Injury Trial in Australia, United States (ZGN-440 sterile diluent, ZGN-440 for injectable
Completed
- Obesity
- +3 more
- ZGN-440 sterile diluent
- ZGN-440 for injectable suspension
-
St. Paul, Minnesota
- +3 more
Jul 14, 2016
Obesity Trial in Davidson, Nashville (Different levels of cost sharing)
Completed
- Obesity
- Different levels of cost sharing
-
Davidson, North Carolina
- +1 more
Dec 18, 2015
Type 2 Diabetes, Exercise, Obesity Trial in Nashville (Behavioral counseling plus "telephone helpline")
Terminated
- Type 2 Diabetes Mellitus
- +3 more
- Behavioral counseling plus "telephone helpline"
-
Nashville, TennesseeVanderbilt University Medical Center
May 21, 2015
Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)
Completed
- Obesity
- Placebo
- Pramlintide and Metreleptin
-
Birmingham, Alabama
- +32 more
Mar 26, 2015
Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)
Completed
- Overweight
- Obesity
- pramlintide acetate
- +3 more
-
Birmingham, Alabama
- +35 more
Mar 26, 2015
Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary
Completed
- Obesity
- +2 more
- Naltrexone SR 32 mg/bupropion SR 360 mg/ day
- +2 more
-
Fairhope, Alabama
- +52 more
Nov 18, 2014
Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, Ancillary therapy)
Completed
- Obesity
- Overweight
- Naltrexone SR 32 mg/bupropion SR 360 mg/day
- +2 more
-
Phoenix, Arizona
- +35 more
Nov 18, 2014
Prader-Willi Syndrome and Early-onset Morbid Obesity
Completed
- Prader-Willi Syndrome
- Obesity
- Group 1
- Group 2
-
Orange, California
- +3 more
Sep 18, 2014
Diabetes, Obesity Trial in Nashville (Lifestyle counseling)
Completed
- Diabetes
- Obesity
- Lifestyle counseling
-
Nashville, TennesseeColeman Community Recreation Center
Dec 17, 2013